Indivior reported 486M in Loan Capital for its fiscal semester ending in March of 2026.





Loan Capital Change Date
AstraZeneca USD 26.01B 46M Jun/2026
Cassava Sciences USD 0 0 Dec/2024
GlaxoSmithKline GBP 13.95B 65M Jun/2026
Glaxosmithkline GBP 18.53B 1.29B Mar/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Roche Holding CHF 25.22B 2.21B Jun/2026
West Pharmaceutical Services USD 202.9M 100K Jun/2026